Cardlytics Inc (CDLX)
Official siteCOMMUNICATION SERVICES • ADVERTISING AGENCIES • NASDAQ
Market Cap: $7.87M
Last updated: Nov 17, 2026 at 4:13 PM ET
Cardlytics Inc (CDLX) Statistics
Cardlytics (CDLX) has a market cap of $7.87M and an enterprise value of $172.62M. Its share count is up 1003.38% from a year earlier. Its net debt of $164.75M equals 2093.12% of its market cap.
Total Valuation
Enterprise value is 2093.12% above the market cap, as debt exceeds cash.
| Market Cap | $7.87M |
|---|---|
| Enterprise Value | $172.62M |
| Latest price (Nov 17, 2026) | $1.29 |
Key Dates
The next earnings report is expected on Mar 2, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 2, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 90.72% over 52 weeks and trades 48.19% below its 50-day average.
| Beta (1Y) | 1.11 |
|---|---|
| 52-Week Change | -90.72% |
| 1-Month Change | -29.89% |
| 3-Month Change | -69.72% |
| 6-Month Change | -78.36% |
| 5-Year Change | -99.77% |
| Total Return (1Y) | -90.72% |
| Total Return (3Y CAGR) | -74.46% |
| Total Return (5Y CAGR) | -72.07% |
| Return vs SPY (1Y) | -101.07% |
| Max Drawdown (1Y) | -91.51% |
| Max Drawdown (3Y) | -99.36% |
| Sharpe Ratio (1Y) | -2.49 |
| Correlation with SPY (1Y) | 0.17 |
| 50-Day Average | $2.49 |
| 200-Day Average | $5.63 |
| 52-Week Range | $1.26 to $15.55 |
| RSI (14 Days) | 27.2 |
| Average Volume (20 Days) | 76.05K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.82x current liabilities.
| Current Ratio | 1.82x |
|---|---|
| Quick Ratio | 1.82x |
Returns and Efficiency
Return on invested capital is -12.20% over the last 12 months, against a 5-year average of -39.59%.
| Return on Assets (ROA) | -16.00% |
|---|---|
| Return on Invested Capital (ROIC) | -12.20% |
| Return on Capital Employed (ROCE) | -15.10% |
| ROA (5Y Average) | -37.08% |
| ROIC (5Y Average) | -39.59% |
| Asset Turnover | 0.61x |
| Receivables Turnover | 2.41x |
Scores
CDLX has an Altman Z-Score of -8.21, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -8.21 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $160.18M over the last 12 months is down 31.97% from the 12 months before.
| Revenue | $160.18M |
|---|---|
| Revenue Growth (YoY) | -31.97% |
| Gross Profit | $160.18M |
| Operating Income | -$25.23M |
| Pretax Income | -$38.13M |
| Net Income | -$36.55M |
| EBITDA | -$5.02M |
| EBIT | -$26.50M |
| Reported EPS (TTM) | -$3.60 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $29.95M |
|---|---|
| Total Debt | $194.69M |
| Net Debt | $164.75M |
| Net Debt Per Share | $27.91 |
| Working Capital | $43.44M |
| Shareholder Equity | -$23.02M |
| Tangible Book Value | -$148.63M |
| Total Assets | $228.51M |
| Total Liabilities | $251.54M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $9.16M of capital spending, operating cash flow left -$16.29M of free cash flow.
| Operating Cash Flow | -$7.13M |
|---|---|
| Capital Expenditures | $9.16M |
| Free Cash Flow | -$16.29M |
| FCF Per Share | -$2.77 |
| Depreciation and Amortization | $21.48M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -15.75%, against a 5-year average of -71.40%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | -15.75% |
| Pretax Margin | -23.81% |
| Net Margin | -22.82% |
| EBITDA Margin | -3.13% |
| EBIT Margin | -16.54% |
| FCF Margin | -10.17% |
| Operating Margin (5Y Average) | -71.40% |
| Net Margin (5Y Average) | -71.99% |
Growth
Revenue fell 7.89% a year over 3 years.
| Revenue Growth (3Y CAGR) | -7.89% |
|---|---|
| Revenue Growth (5Y CAGR) | +4.53% |
Dividends and Yields
CDLX does not pay a dividend. Its free cash flow yield is -214.00%.
| FCF Yield | -214.00% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-10 reverse split on Jun 8, 2026.
| Last Split Date | Jun 8, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Peer Position
Against 7 similar companies, CDLX has the 6th highest ROIC.
ROICPeer median 0.70%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -2.08%
| ROIC | -12.20% vs 0.70% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -31.97% vs -2.08% median |
Analyst Forecast
Consensus estimates put revenue growth at -19.48% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -19.48% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CDLX
What is CDLX's market cap?
Cardlytics has a market cap of $7.87M. Its enterprise value, which adds debt and subtracts cash, is $172.62M.
How many shares of CDLX are outstanding?
Cardlytics has 5.90M shares outstanding. The count is up 1003.38% from a year earlier.
Does CDLX pay a dividend?
No. Cardlytics does not pay a dividend.
How much debt does CDLX have?
Cardlytics has $194.69M of total debt and $29.95M of cash and equivalents, a net debt position of $164.75M.
CDLX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors